US › Healthcare

Scienture Holdings, Inc. (SCNX)

US · Healthcare · Pharmaceutical Retailers

$0.38-2.84%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$56,325

Revenue YoY

+449.1%

Net profit

$-3.4M

Profit YoY

-11.0%

EPS

$-0.08

EPS estimate

$-0.22

Net margin

-6,040.4%

EPS came in at -0.08 against a street estimate of -0.22 — a beat of 63.6%.

Key statistics

Market cap

$15.5M

Forward P/E

21.8

P/B

0.23

Book value

$1.65

EPS (TTM)

$-2.45

52-week high

$2.60

52-week low

$0.24

50-day MA

$0.38

200-day MA

$0.49

Beta

4.08

Analyst view

with an average price target of $1.50.

Shareholding

Insiders

13.31%

Institutions

3.76%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	1.06%
Vanguard Capital Management, LLC	1.00%
Vanguard Fiduciary Trust Co	0.49%
UBS Group AG	0.27%
Virtu Financial LLC	0.21%
XTX Topco Ltd	0.12%
TWO SIGMA SECURITIES, LLC	0.09%
Jane Street Group LLC	0.07%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Scienture Holdings, Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.